AU7198291A - Human monoclonal antibodies against rabies viruses, the production and the use thereof - Google Patents
Human monoclonal antibodies against rabies viruses, the production and the use thereofInfo
- Publication number
- AU7198291A AU7198291A AU71982/91A AU7198291A AU7198291A AU 7198291 A AU7198291 A AU 7198291A AU 71982/91 A AU71982/91 A AU 71982/91A AU 7198291 A AU7198291 A AU 7198291A AU 7198291 A AU7198291 A AU 7198291A
- Authority
- AU
- Australia
- Prior art keywords
- production
- monoclonal antibodies
- antibodies against
- human monoclonal
- rabies viruses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000711798 Rabies lyssavirus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4006630 | 1990-03-03 | ||
DE4006630A DE4006630A1 (en) | 1990-03-03 | 1990-03-03 | HUMANE MONOCLONAL ANTIBODIES AGAINST RABBIT VIRUSES, THEIR PRODUCTION AND USE |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7198291A true AU7198291A (en) | 1991-09-05 |
AU634030B2 AU634030B2 (en) | 1993-02-11 |
Family
ID=6401309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU71982/91A Ceased AU634030B2 (en) | 1990-03-03 | 1991-03-01 | Human monoclonal antibodies against rabies viruses, the production and the use thereof |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0445625A1 (en) |
JP (1) | JPH05301894A (en) |
KR (1) | KR910016346A (en) |
AU (1) | AU634030B2 (en) |
CA (1) | CA2037446A1 (en) |
DE (1) | DE4006630A1 (en) |
IE (1) | IE910697A1 (en) |
PT (1) | PT96908A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7579446B2 (en) | 2004-05-27 | 2009-08-25 | Crucell Holland B.V. | Binding molecules capable of neutralizing rabies virus and uses thereof |
US7959922B2 (en) | 2006-12-05 | 2011-06-14 | Crucell Holland B.V. | Liquid anti-rabies antibody formulations |
US8211431B2 (en) | 2006-06-06 | 2012-07-03 | Crucell Holland B.V. | Human binding molecules having killing activity against staphylococci and uses thereof |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2344208A1 (en) | 2001-04-30 | 2002-10-30 | Oxford Biomedica (Uk) Limited | Method |
CN1665528B (en) | 2002-07-05 | 2013-05-15 | 弗利亚生物技术公司 | Adjuvant viral particle |
US8101189B2 (en) | 2002-07-05 | 2012-01-24 | Folia Biotech Inc. | Vaccines and immunopotentiating compositions and methods for making and using them |
CA2965865C (en) | 2002-07-18 | 2021-10-19 | Merus N.V. | Recombinant production of mixtures of antibodies |
USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
CA2527694C (en) | 2003-05-30 | 2015-07-14 | Hendricus Renerus Jacobus Mattheus Hoogenboom | Fab library for the preparation of anti vegf and anti rabies virus fabs |
US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
JP5912211B2 (en) | 2004-01-20 | 2016-04-27 | メルス ビー.ヴィー. | Mixture of binding proteins |
GB0526210D0 (en) | 2005-12-22 | 2006-02-01 | Oxford Biomedica Ltd | Vectors |
ES2762864T3 (en) | 2008-06-18 | 2020-05-26 | Oxford Biomedica Ltd | Virus purification |
JP2010085126A (en) * | 2008-09-29 | 2010-04-15 | Adtec Kk | Determination instrument for determining neutralizing antibody titer of rabies virus, and method for measuring neutralizing antibody titer of rabies virus |
WO2011148194A1 (en) | 2010-05-28 | 2011-12-01 | Oxford Biomedica (Uk) Ltd | Delivery of lentiviral vectors to the brain |
GB201118636D0 (en) | 2011-10-28 | 2011-12-07 | Oxford Biomedica Ltd | Nucleotide sequence |
MX360110B (en) | 2012-04-20 | 2018-10-23 | Merus Nv | Methods and means for the production of ig-like molecules. |
CN103954777A (en) * | 2014-05-20 | 2014-07-30 | 北京凯思百奥科技发展有限公司 | Rabies virus monoclonal antibody and application thereof |
WO2019227039A1 (en) * | 2018-05-24 | 2019-11-28 | Lankenau Institute For Medical Research | Compositions comprising antibodies to rabies virus and the uses thereof |
US20220175962A1 (en) | 2019-03-10 | 2022-06-09 | Sio Gene Therapies Inc. | Gene therapy compositions and methods for treating parkinson's disease |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0131878A3 (en) * | 1983-07-19 | 1987-08-05 | Sloan-Kettering Institute For Cancer Research | Process for producing human monoclonal antibodies |
WO1989009789A1 (en) * | 1988-04-07 | 1989-10-19 | Farmitalia Carlo Erba S.R.L. | Human monoclonal antibodies against rabies virus |
DE69005908T2 (en) * | 1989-06-08 | 1994-04-28 | Wistar Inst Philadelphia | Monoclonal antibodies for treatment after contact with rabies virus. |
-
1990
- 1990-03-03 DE DE4006630A patent/DE4006630A1/en not_active Withdrawn
-
1991
- 1991-02-26 EP EP91102804A patent/EP0445625A1/en not_active Withdrawn
- 1991-02-28 PT PT96908A patent/PT96908A/en not_active Application Discontinuation
- 1991-03-01 AU AU71982/91A patent/AU634030B2/en not_active Ceased
- 1991-03-01 CA CA002037446A patent/CA2037446A1/en not_active Abandoned
- 1991-03-01 IE IE069791A patent/IE910697A1/en unknown
- 1991-03-02 JP JP3061286A patent/JPH05301894A/en active Pending
- 1991-03-02 KR KR1019910003427A patent/KR910016346A/en not_active Application Discontinuation
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7579446B2 (en) | 2004-05-27 | 2009-08-25 | Crucell Holland B.V. | Binding molecules capable of neutralizing rabies virus and uses thereof |
US7740852B2 (en) | 2004-05-27 | 2010-06-22 | Crucell Holland B.V. | Binding molecules capable of neutralizing rabies virus and uses thereof |
US8148497B2 (en) | 2004-05-27 | 2012-04-03 | Crucell Holland B.V. | Binding molecules capable of neutralizing rabies virus and uses thereof |
US9005624B2 (en) | 2004-05-27 | 2015-04-14 | Crucell Holland B.V. | Binding molecules capable of neutralizing rabies virus and uses thereof |
US8211431B2 (en) | 2006-06-06 | 2012-07-03 | Crucell Holland B.V. | Human binding molecules having killing activity against staphylococci and uses thereof |
US8460666B2 (en) | 2006-06-06 | 2013-06-11 | Crucell Holland B.V. | Human binding molecules having killing activity against staphylococci and uses thereof |
US7959922B2 (en) | 2006-12-05 | 2011-06-14 | Crucell Holland B.V. | Liquid anti-rabies antibody formulations |
Also Published As
Publication number | Publication date |
---|---|
IE910697A1 (en) | 1991-09-11 |
KR910016346A (en) | 1991-11-05 |
JPH05301894A (en) | 1993-11-16 |
EP0445625A1 (en) | 1991-09-11 |
PT96908A (en) | 1991-10-31 |
AU634030B2 (en) | 1993-02-11 |
CA2037446A1 (en) | 1991-09-04 |
DE4006630A1 (en) | 1991-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7198291A (en) | Human monoclonal antibodies against rabies viruses, the production and the use thereof | |
IL101690A0 (en) | Antibodies and methods utilizing the same | |
ZA964710B (en) | Novel compounds, the preparation and use thereof. | |
AU1218295A (en) | Adjuvant for antigens, process for producing the same and its use | |
AU9075591A (en) | N-halochitosans, their preparation and uses | |
EP0458333A3 (en) | Polyisocyanato-isocyanurate, and preparation process and use of the same | |
EP0468464A3 (en) | Cellulase, method for producing the same and use thereof | |
IL95775A0 (en) | Oxazole-and thiazole-carboxamides,their manufacture and their use as herbicides | |
AU3424195A (en) | UV absorbers, their preparation and the use thereof | |
AU5641798A (en) | Artificial antibodies, method of producing the same and use thereof | |
EP0245993A3 (en) | Monoclonal antibodies against c5a and des-arg74-c5a, their production and use | |
EP0805161A4 (en) | (1-3)-beta-d-glucan-binding protein, antibody that recognizes the protein, and use of the protein and antibody | |
EP0341684A3 (en) | Human monoclonal antibody, hybridoma producing the same and pharmaceutical | |
AU1140197A (en) | Pyridyl carbamates, process and intermediates for the preparation and use thereof | |
GB2246139B (en) | Polytheresters,their production and use | |
AU3064495A (en) | UV absorbers, their preparation and the use thereof | |
AU8876591A (en) | Indole-3-methanamines useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents | |
AU8271191A (en) | Indolonaphthyridines, their production and use | |
AU7504691A (en) | Monoclonal antibodies against pp4, processes for the preapration thereof and the use thereof | |
AU4115796A (en) | Iminooxymethylene anilides, process for preparing the same and their use | |
AU4174789A (en) | Hybrid monoclonal antibodies, their production and use | |
AU9139591A (en) | Process for the preparation of bromonitro-alcohols, dibromonitro-alcohols and blends thereof | |
AU1201995A (en) | Fixture comprising bryothyte for greening, process for producing the fixture, and use thereof | |
AU3432389A (en) | Human monoclonal antibodies against rabies virus | |
AU4314693A (en) | Pyrimidinyl- and triazinyl- salicyl- and picolylamides and the use, as herbicides, and preparation thereof |